Fresh off its $13-billion acquisition of medical devices developer Shockwave Medical, Johnson & Johnson is expecting greater business growth in the future.

Shineco, Inc. today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses.

Bedal International today announces the successful closing of a $11 million funding round.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024 results after the financial markets close on Thursday, August 1, 2024.

Nevro Corp. announced that on July 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 69,201 shares of Nevro's common stock to 17 new non-executive employees to induce them to accept employment with Nevro.

AllMeD Solutions announced subsidiary TruLeaf Medical's receipt of the Helsinki Ethics Committee's approval in Uzbekistan to conduct clinical trial in human subjects.